-
-
-
-
-
-
-
Raymond James Reiterates Outperform Rating on Compass Therapeutics (CMPX) following Q4 results
-
-
-
-
-
-
-
Compass Therapeutics Reports 2025 Second Quarter Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Compass Therapeutics Reports 2024 Third Quarter Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Compass Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Compass Therapeutics Reports First Quarter 2022 Financial Results and Highlights Recent Company Progress
-
-
-
-
1,198,990 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

